Compulsory Licensing

Abbott recently sought compulsory license in US patent dispute

Sunday, 29 April 2007

(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
 

On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.

 

Balanced agenda reached at the conclusion of WIPO patent committee

The Summary by the Chair of the WIPO Standing Committee Committee on the Law of Patents’ (SCP) Thirteenth Session which took place in Geneva from March 23, 2009 to March 27, 2009 has been posted on the WIPO website.

Notes from Day one of WIPO SCP 13

WIPO’s five day 13th meeting of the Standing Committee on the Law of Patents (SCP) began on Monday, and will go through Friday. The agenda is quite full, as the SCP will consider four important reports written by the Secretariat.

SCP/13/2: Standards and Patents
SCP/13/3: Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP/13/4: The Client-Attorney Privilege
SCP/13/5: Dissemination of Patent Information

WIPO SCP 13, slides from KEI Side event on Patents and Standards

On March 23, 2009, Knowledge Ecology International (KEI) organized a Briefing on Patents and Standards at WIPO’s 13th meeting of the Standing Committee on Patents (SCP). The meeting features presentations from Dr. Baisheng An, a Research Fellow at the South Centre, George Greve, President of Free Software Foundation Europoe (FSFE), Ahmed Abedel Latif, of the International Centre for Trade and Sustainable Development (ICTSD), and James Love, Knowledge Ecology International (KEI).

PhRMA Special 301 submission on Thailand

The following discusses the 2009 PhRMA submission for the USTR Special 301 list on Thailand. Thailand is one of three Asian countries (China, Philippines and Thailand) that were singled out by PhRMA for the harshest treatment. The submission on Thailand covers several topics, including these:

PhRMA’s Aggressive Special 301 submission for the Philippines

One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR.

India: Intervention at WTO TRIPS Council on public health dimension of the TRIPS Agreement

On 3 March 2009, India delivered the following intervention at the WTO Council for TRIPS meeting on the issue of the public health dimension of the TRIPS Agreement in the context of the Dutch seizures.

_______________________________________________________________________

INTERVENTION by INDIA

Agenda item ‘M’ – OTHER BUSINESS – Public Health dimension of TRIPS Agreement
Chair,

Trade-off between access and incentives

This is a comment on the references to compulsory licensing in the Hollis/Pogge HIF book that are quoted below.

http://www.keionline.org/blogs/2008/11/18/excerpts-from-hif-compulsory-licensing/
Aidan Hollis and Thomas Pogge, The Health Impact Fund, Making New Medicines Accessible for All, A Report of Incentives for Global Health, 2008.

BMZ funded UNCTAD Thailand meeting on IPR, medicines

UNCTAD head Supachai Panitchpakdi will open up this December 16-19 event in Bangkok. The meeting is funded by the Federal Ministry for Economic Cooperation and Development (BMZ), Germany.


Programme Events

Event: Symposium on Flexibilities in International Intellectual Property Rules and Local Production of Medicines
Date: 16–19 December 2008
Location: Bangkok, Thailand
Venue: Conference Room of Arnoma Hotel
Description:

Syndicate content